Sodium Citrate/ Sodium Lauryl Sulphoacetate/ Sorbitol
Indications
Registered South African indications:
- Relief of occasional constipation and for use as a bowel cleansing regimen in preparation for X-ray examination and rectoscopy
Contraindications (ZA)
Registered South African contraindications
- Hypersensitivity to the active ingredients or any of the excipients in this combination product
- Inherited fructose intolerance
Warnings & precautions
South African recommendations
Caution in the following patient groups
- Pregnancy
- Breastfeeding
- Renal impairment
- Severe hepatic impairment
- Elderly
Use in specific conditions
- Sodium citrate/sodium lauryl sulphoacetate/sorbitol should not be used in the presence of abdominal pain, nausea, or vomiting
Duration of use
- This product should not be used for a period longer than one week unless directed by a doctor
Change in bowel habits
- If a sudden change in bowel habits persists for more than 2 weeks, a doctor should be consulted before using the enema
Rectal bleeding and bowel movement failure
- Rectal bleeding or failure to have a bowel movement after use of a laxative may indicate a serious condition. Use should be discontinued and a doctor consulted
Excipient precautions
- Care should be taken when administering preparations containing sorbitol to patients with impaired kidney function or severe liver damage
Adult dosage (ZA)
Forms avail. in SA and covered in this monograph: ene
South African registered indications and dosages
Relief of occasional constipation and for use as a bowel cleansing regimen in preparation for X-ray examination and rectoscopy
Sodium Citrate/ Sodium Lauryl Sulphoacetate 70%/ Sorbitol
90/12.9/893 (mg/ml)
- Rectal (ene): 5ml (contents of one tube), with the nozzle inserted completely into the rectum; Desired effect usually occurs within 5-15mins
Directions for use
Twist and pull the seal off the nozzle. Squeeze the tube slightly so that a drop appears at the tip in order to provide lubrication for easier insertion. In adults insert the nozzle completely into the rectum. Empty the entire contents of the tube into the rectum by squeezing the shoulder of the tube. Withdraw the nozzle whilst keeping the tube completely compressed
Paediatric dosage (ZA)
Paed. forms avail. in SA and covered in this monograph: ene
South African registered indications and dosages
Relief of occasional constipation and for use as a bowel cleansing regimen in preparation for X-ray examination and rectoscopy
Sodium Citrate/ Sodium Lauryl Sulphoacetate 70%/ Sorbitol
90/12.9/893 (mg/ml)
- Rectal (ene): 5ml (contents of one tube), inserted into the rectum; Desired effect usually occurs within 5-15mins
Directions for use
Twist and pull the seal off the nozzle. Squeeze the tube slightly so that a drop appears at the tip in order to provide lubrication for easier insertion. Note: for children under 3 years of age only half the length of the nozzle should be inserted into the rectum (as indicated on the nozzle). Empty the entire contents of the tube into the rectum by squeezing the shoulder of the tube. Withdraw the nozzle whilst keeping the tube completely compressed
Pregnancy & lactation
Pregnancy
South African recommendations
- Caution; no information available
Breastfeeding
South African recommendations
- Caution; no information available
Fertility
South African recommendations
- No information available
Renal impairment
South African recommendations
- Caution; no dose adjustment recommended
Care should be taken when administering preparations containing sorbitol to patients with impaired kidney function
Hepatic impairment
South African recommendations
- Mild to moderate: No information available
- Severe: Caution; no dose adjustment recommended
Care should be taken when administering preparations containing sorbitol to patients with severe liver damage
Elderly
South African recommendations
- Caution; no information available
Adverse reactions
Gastrointestinal Disorders
Occasional
- Rectal burning sensation
Immune System Disorders
Frequency not known
- Hypersensitivity (general skin reaction with or without hypotension or respiratory distress)
Interactions
No information available
Monitoring
None routine
Mechanism of action
Sodium Citrate/ Sodium Lauryl Sulphoacetate/ Sorbitol attracts water into the faecal mass, thus producing a soft motion which may be easily evacuated.
Dosage forms
- Enema
Formulation
Sodium Citrate/ Sodium Lauryl Sulphoacetate 70%/ Sorbitol
Enema (per ml) 90mg/ 12.9mg/ 893mg
- Microlax Microenema (Johnson & Johnson)
References
1. PI - Microlax PI SAHPRA - Johnson & Johnson (Pty) Ltd - Date of publication - December 1995 - Received from Pharma 12 May 2025.pdf [https://medsinfoportal.sahpra.org.za/pi/35a76671183d67a68bf445905eb579c5.pdf] 2. SAIDS - Medication Check - Drug Free Sport - Microlax enema - Downloaded online 12 May 2025.pdf [https://drugfreesport.org.za/online-medication-check/] 3. NAPOS - A06AG11 - Sodium lauryl solfoacetate incl combinations - NP - Downloaded online 12 May 2025.pdf [https://drugs-porphyria.org/monograph/335/A06AG11] * No SmPC checked 12 May 2025 * No U2D checked 12 May 2025
Brands & products
0 products · cached snapshot- Microlax
- Microlax Microenema
Medical aid coverage
data not yet integrated- Comprehensive Series—
- Executive Plan—
- KeyCare Series—
- Priority Series—
- Saver Series—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- BonClassic—
- BonComprehensive—
- BonEssential—
- BonFit Select—
- BonSave—
- BonStart—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Beryl—
- Emerald—
- Onyx—
- Ruby—
- Sapphire—
- Tanzanite One—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Aquarium Option—
- Efficiency Option—
- Marine Option—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.